These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 9226741

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Alginic acid effect on carteolol ocular pharmacokinetics in the pigmented rabbit.
    Tissié G, Sébastian C, Elena PP, Driot JY, Trinquand C.
    J Ocul Pharmacol Ther; 2002 Feb; 18(1):65-73. PubMed ID: 11858616
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.
    Ishizaki T, Ohnishi A, Sasaki T, Kushida K, Horai Y, Chiba K, Suganuma T.
    Eur J Clin Pharmacol; 1983 Feb; 25(1):95-101. PubMed ID: 6137389
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Simple and reliable radioreceptor assay for beta-adrenoceptor antagonists and active metabolites in native human plasma.
    Wellstein A, Palm D, Wiemer G, Schäfer-Korting M, Mutschler E.
    Eur J Clin Pharmacol; 1984 Feb; 27(5):545-53. PubMed ID: 6151508
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and pharmacodynamic differences between ocular and nasal instillation of carteolol on intraocular pressure and heart rate in Japanese men with high CYP2D6 activity.
    Ishii Y, Nakamura K, Matsuki S, Uemura N, Muraguchi R, Nakagawa M, Nakano S, Nakatsuka K.
    J Clin Pharmacol; 2002 Sep; 42(9):1020-6. PubMed ID: 12211218
    [Abstract] [Full Text] [Related]

  • 13. [Long-acting carteolol hydrochloride 2% ophthalmic solution phase IV study--investigation of the effectiveness, safety and plasma concentration].
    Kawase K, Yamamoto T, Muramatsu T, Ono J, Nakajima T, Matsuhisa A, Sugiura T, Migita M, Ishikawa Y.
    Nippon Ganka Gakkai Zasshi; 2010 Nov; 114(11):976-82. PubMed ID: 21141077
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs.
    Arsenault WG, Boothe DM, Gordon SG, Miller MW, Chalkley JR, Petrikovics I.
    Am J Vet Res; 2005 Dec; 66(12):2172-6. PubMed ID: 16379664
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Concentration-effect and time-effect relationships of carteolol.
    Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T, Kushida K.
    Eur J Clin Pharmacol; 1983 Dec; 25(6):749-57. PubMed ID: 6141053
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.